Tumorigenicity assay essential for facilitating safety studies of hiPSC-derived cardiomyocytes for clinical application
about
Tumorigenicity assay essential for facilitating safety studies of hiPSC-derived cardiomyocytes for clinical application
description
article publié dans la revue scientifique Scientific Reports
@fr
im Februar 2019 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published in Scientific Reports
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 2019
@uk
name
Tumorigenicity assay essential ...... cytes for clinical application
@en
Tumorigenicity assay essential ...... cytes for clinical application
@nl
type
label
Tumorigenicity assay essential ...... cytes for clinical application
@en
Tumorigenicity assay essential ...... cytes for clinical application
@nl
prefLabel
Tumorigenicity assay essential ...... cytes for clinical application
@en
Tumorigenicity assay essential ...... cytes for clinical application
@nl
P2093
P1433
P1476
Tumorigenicity assay essential ...... cytes for clinical application
@en
P2093
Ai Kawamura
Akima Harada
Hiroko Iseoka
Maki Takeda
Nagako Sougawa
Noriko Mochizuki-Oda
Shigeru Miyagawa
Shin Yajima
P356
10.1038/S41598-018-38325-5
P407
P577
2019-02-13T00:00:00Z